Top Markets
#1 DeFiChain DeFiChain +1,198.24%
#2 Superfortune Superfortune +102.78%
#3 V.I.T.R.I.O.L. Network V.I.T.R.I.O.L. Network +82.96%
#4 The Black Bull The Black Bull +80.59%
#5 Metaplex Metaplex +79.35%
#6 TokenOS AI TokenOS AI +59.62%
#7 Nexus Nexus +56.52%
#8 Alien Worlds Alien Worlds +55.53%
#9 Magma Finance Magma Finance +47.14%
#10 Hamster Kombat Hamster Kombat +36.70%
Coin of the day
DeFiChain DeFiChain
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Virbac SA Virbac SA

Virbac SA

VIRP
Rang in aandelen #3592
Virbac SA manufactures and sells a range of products and services for companion... Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Aandeelprijs
$393.80
Marktkapitalisatie
$3.30B
Verandering (1 dag)
0.15%
Verandering (1 jaar)
4.67%
Land
FR
Handel Virbac SA (VIRP)

Categorie

Healthcare
Aandelsplitsingen voor Virbac SA (VIRP)
Het aandeel Virbac SA (symbool: VIRP) heeft in totaal 1 splitsingen ondergaan.
De meest recente splitsing vond plaats op Jul 30, 2002.
Eén aandeel VIRP dat vóór Jul 30, 2002 werd gekocht, staat nu gelijk aan 4 aandelen VIRP.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
2002-07-30 4:1 x4 x4
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
 4 x15
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7 x432
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 0 -
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 7 x226
US
Novartis AG Novartis AG
Novartis AG
NVS.US
 2 x2
CH